Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Change in Inventory of $4.0 million for Q1 2026, up 300.0% year-over-year from $1.0 million in Q1 2025, and up 2766.67% on a QoQ basis from -$150000.0 in Q4 2025.
Ultragenyx Pharmaceutical (RARE) has 9 years of Change in Inventory data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Change in Inventory rose 300.0% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (down 8.87% YoY) and the FY2025 annual result came in at $6.0 million, down 45.45% from the prior year.
- Change in Inventory advanced to $4.0 million in Q1 2026 per RARE's latest filing, from -$150000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $5.6 million in Q3 2025 and bottomed at -$445000.0 in Q2 2025.
- The 5-year median for Change in Inventory is $2.1 million (2024), against an average of $2.2 million.
- The widest annual swing landed in 2022, when Change in Inventory surged 1782.98%; it then tumbled 110.78% in 2025.
- Tracing RARE's Change in Inventory over 5 years: stood at $4.2 million in 2022, then tumbled by 51.82% to $2.0 million in 2023, then gained by 11.01% to $2.2 million in 2024, then slumped by 106.67% to -$150000.0 in 2025, then jumped by 2766.67% to $4.0 million in 2026.
- Per Business Quant, the three latest RARE Change in Inventory figures stand at $4.0 million (Q1 2026), -$150000.0 (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | -445,000.00 |
| Jun 30, 2025 | -445,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | -150,000.00 |
| Mar 31, 2023 | -150,000.00 |
| Dec 31, 2022 | 4.21 Mn |
| Dec 31, 2022 | 4.21 Mn |
| Sep 30, 2022 | 791,000.00 |
| Sep 30, 2022 | 791,000.00 |
| Jun 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 990,000.00 |
| Dec 31, 2021 | 990,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | 2.65 Mn |
| Jun 30, 2021 | 2.65 Mn |
| Mar 31, 2021 | -474,000.00 |
| Mar 31, 2021 | -474,000.00 |
| Dec 31, 2020 | -1.29 Mn |
| Dec 31, 2020 | -1.29 Mn |
| Sep 30, 2020 | 3.16 Mn |
| Sep 30, 2020 | 3.16 Mn |
| Jun 30, 2020 | -372,000.00 |
| Jun 30, 2020 | -372,000.00 |
| Mar 31, 2020 | -149,000.00 |
| Mar 31, 2020 | -149,000.00 |
| Dec 31, 2019 | -2.15 Mn |
| Dec 31, 2019 | -2.15 Mn |
| Sep 30, 2019 | 564,000.00 |
| Sep 30, 2019 | 564,000.00 |
| Jun 30, 2019 | 2.39 Mn |
| Jun 30, 2019 | 2.39 Mn |
| Mar 31, 2019 | 3.65 Mn |
| Mar 31, 2019 | 3.65 Mn |
| Dec 31, 2018 | 484,000.00 |
| Dec 31, 2018 | 484,000.00 |
| Sep 30, 2018 | 2.21 Mn |
| Sep 30, 2018 | 2.21 Mn |
| Jun 30, 2018 | 1.27 Mn |
| Jun 30, 2018 | 1.27 Mn |
| Mar 31, 2018 | 1.31 Mn |
| Mar 31, 2018 | 1.31 Mn |